CARCINOID TUMOR
Clinical trials for CARCINOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new CARCINOID TUMOR trials appear
Sign up with your email to follow new studies for CARCINOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tests the drug pembrolizumab in about 1,600 people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can shrink tumors and to identify biomarkers that predict response. Participants receive pembrolizumab and are m…
Matched conditions: CARCINOID TUMOR
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 07:12 UTC
-
New hope for neuroendocrine tumors: cabozantinib shows promise in Late-Stage trial
Disease control OngoingThis phase 3 study tests the drug cabozantinib against a placebo in 298 people with advanced neuroendocrine tumors (including carcinoid tumors) that have worsened after prior treatment. Cabozantinib is a targeted therapy that may slow or stop tumor growth by blocking certain prot…
Matched conditions: CARCINOID TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New CT technique may spot hidden gut tumors
Diagnosis OngoingThis study tests whether a special type of CT scan, called dual energy CT, can better detect carcinoid tumors in the digestive system. About 71 people with signs or confirmed carcinoid tumors will get this scan during their routine imaging. The goal is to see if this technique im…
Matched conditions: CARCINOID TUMOR
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 26, 2026 07:06 UTC